Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT02938468
Eligibility Criteria:
Inclusion Criteria:
* age ≥ 18 yrs
* subacute/chronic subdural hematoma on CT or MRI performed within 72 hours prior to recruitment
* patient must be symptomatic
Exclusion Criteria:
* Glasgow Coma Scale (GCS) ≤ 12
* patients needing craniotomy at the discretion of the on call neurosurgeon
* hemiparesis with less than antigravity (≤ 3/5 medical research council scale) strength in any testable myotomes
°≥ 2 seizures at presentation or history of epilepsy
* subdural hematoma with an underlying lesion or condition such as tumor, arachnoid cyst, presence of a ventriculoperitoneal shunt or vascular malformation
* contraindication to dexamethasone including allergy or hypersensitivity to dexamethasone, immunocompromised/immunosuppressed patients, uncontrolled diabetes, untreated known peptic ulcer disease
* pregnant/breastfeeding mothers
* acute infection including latent/active tuberculosis (TB)
* history of psychosis
* anticoagulated for mechanical heart valve or arterial stent (i.e. coronary, carotid, or peripheral) placement
* small volume, non-operable subdural collection
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02938468
Study Brief:
Protocol Section:
NCT02938468